|
"liu chen hua"的相關文件
顯示項目 31-40 / 153 (共16頁)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目
| 臺大學術典藏 |
2018-09-10T09:49:22Z |
Longitudinal Change of HBsAg in HBeAg-negative Patients with Genotype B or C Infection
|
Su, T.-H., Liu, C.-J., Tseng, T.-C., Liu, C.-H., Yang, H.-C., Chen, C.-L., Chen, P.-J., Kao, J.-H., Chen, D.-S.; Su, Tung-Hung;Liu, Chun-Jen;Tseng, Tai-Chung;Liu, Chen-Hua;Yang, Hung-Chih;Chen, Chi-Ling;Chen, Pei-Jer;Kao, Jia-Horng;Chen, Ding-Shinn; 陳定信 ;劉振驊 ;高嘉宏 ;楊宏志 ;蘇東弘 ;劉俊人 ;陳培哲 ;陳祈玲; Su, Tung-Hung; Su, Tung-Hung; CHUN-JEN LIU; Liu, Chun-Jen; Liu, Chun-Jen; PEI-JER CHEN; CHEN-HUA LIU; Tseng, Tai-Chung; Liu, Chen-Hua; DING-SHINN CHEN; Liu, Chen-Hua; TUNG-HUNG SU; Yang, Hung-Chih; Yang, Hung-Chih; Chen, Chi-Ling; JIA-HORNG KAO; Chen, Pei-Jer; Chen, Pei-Jer; Kao, Jia-Horng; Kao, Jia-Horng; Chen, Ding-Shinn; Chen, Ding-Shinn |
| 臺大學術典藏 |
2018-09-10T09:47:27Z |
Association of IL28B genotypes with metabolic profiles and viral clearance rate in chronic hepatitis C patients
|
Hsu, Ching-Sheng;Hsu, Shih-Jer;Chen, Hung-Chia;Liu, Chen-Hua;Jeng, Jenher;Liu, Chun-Jen;Chen, Pei-Jer;Chen, Ding-Shinn;Kao, Jia-Horng; CHUN-JEN LIU; Hsu, Ching-Sheng; Hsu, Ching-Sheng; PEI-JER CHEN; Hsu, Shih-Jer; Hsu, Shih-Jer; CHEN-HUA LIU; Chen, Hung-Chia; Chen, Hung-Chia; Liu, Chen-Hua; DING-SHINN CHEN; Liu, Chen-Hua; Jeng, Jenher; JIA-HORNG KAO; Liu, Chun-Jen; Liu, Chun-Jen; Chen, Pei-Jer; Chen, Pei-Jer; Chen, Ding-Shinn; Kao, Jia-Horng; Kao, Jia-Horng |
| 臺大學術典藏 |
2018-09-10T09:47:26Z |
Distinct evolution and predictive value of hepatitis B virus precore and basal core promoter mutations in interferon-induced hepatitis B e antigen seroconversion
|
Yang, Hung-Chih;Chen, Chi-Ling;Shen, Yueh-Chi;Peng, Cheng-Yuan;Liu, Chun-Jen;Tseng, Tai-Chung;Su, Tung-Hung;Chuang, Wan-Long;Yu, Ming-Lung;Dai, Chia-Yen;Liu, Chen-Hua;Chen, Pei-Jer;Chen, Ding-Shinn;Kao, Jia-Horng; Yang, Hung-Chih;Chen, Chi-Ling;Shen, Yueh-Chi;Peng, Cheng-Yuan;Liu, Chun-Jen;Tseng, Tai-Chung;Su, Tung-Hung;Chuang, Wan-Long;Yu, Ming-Lung;Dai, Chia-Yen;Liu, Chen-Hua;Chen, Pei-Jer;Chen, Ding-Shinn;Kao, Jia-Horng; Yang, H.-C. and Chen, C.-L. and Shen, Y.-C. and Peng, C.-Y. and Liu, C.-J. and Tseng, T.-C. and Su, T.-H. and Chuang, W.-L. and Yu, M.-L. and Dai, C.-Y. and Liu, C.-H. and Chen, P.-J. and Chen, D.-S. and Kao, J.-H.; 陳定信 ;劉振驊 ;高嘉宏 ;楊宏志 ;蘇東弘 ;劉俊人 ;陳培哲 ;陳祈玲; Yang, Hung-Chih; HUNG-CHIH YANG; CHUN-JEN LIU; Chen, Chi-Ling; Shen, Yueh-Chi; PEI-JER CHEN; Peng, Cheng-Yuan; CHEN-HUA LIU; TUNG-HUNG SU; Liu, Chun-Jen; Liu, Chun-Jen; Tseng, Tai-Chung; DING-SHINN CHEN; Tseng, Tai-Chung; Su, Tung-Hung; Su, Tung-Hung; JIA-HORNG KAO; Chuang, Wan-Long; Yu, Ming-Lung; Dai, Chia-Yen; Liu, Chen-Hua; Liu, Chen-Hua; Chen, Pei-Jer; Chen, Pei-Jer; Chen, Ding-Shinn; Chen, Ding-Shinn; Kao, Jia-Horng |
| 臺大學術典藏 |
2018-09-10T09:47:24Z |
Serum microRNA-122 level correlates with virologic responses to pegylated interferon therapy in chronic hepatitis C
|
Su, Tung-Hung;Liu, Chen-Hua;Liu, Chun-Jen;Chen, Chi-Ling;Ting, Te-Tien;Tseng, Tai-Chung;Chen, Pei-Jer;Kao, Jia-Horng;Chen, Ding-Shinn; Su, Tung-Hung;Liu, Chen-Hua;Liu, Chun-Jen;Chen, Chi-Ling;Ting, Te-Tien;Tseng, Tai-Chung;Chen, Pei-Jer;Kao, Jia-Horng;Chen, Ding-Shinn; Su, T.-H. and Liu, C.-H. and Liu, C.-J. and Chen, C.-L. and Ting, T.-T. and Tseng, T.-C. and Chen, P.-J. and Kao, J.-H. and Chen, D.-S.; 陳定信 ;劉振驊 ;高嘉宏 ;蘇東弘 ;劉俊人 ;陳培哲 ;陳祈玲; Su, Tung-Hung; Su, Tung-Hung; CHUN-JEN LIU; Liu, Chen-Hua; Liu, Chen-Hua; PEI-JER CHEN; CHEN-HUA LIU; Liu, Chun-Jen; Liu, Chun-Jen; Chen, Chi-Ling; TUNG-HUNG SU; Ting, Te-Tien; DING-SHINN CHEN; JIA-HORNG KAO; Tseng, Tai-Chung; Chen, Pei-Jer; Chen, Pei-Jer; Kao, Jia-Horng; Kao, Jia-Horng; Chen, Ding-Shinn; Chen, Ding-Shinn; 陳祈玲 |
| 臺大學術典藏 |
2018-09-10T09:39:55Z |
Sustained hepatitis C virus clearance and increased hepatitis B surface antigen seroclearance in patients with dual chronic hepatitis C and B during posttreatment follow-up.
|
Yu, Ming-Lung; HUNG-CHIH YANG; CHUN-JEN LIU; Lee, Chuan-Mo; Lee, Chuan-Mo; PEI-JER CHEN; Chen, Chi-Ling; Chen, Chi-Ling; CHEN-HUA LIU; Chuang, Wan-Long; Lu, Sheng-Nan; Lu, Sheng-Nan; DING-SHINN CHEN; Liu, Chen-Hua; JIA-HORNG KAO; Liu, Chen-Hua; Wu, Shun-Sheng; Wu, Shun-Sheng; Liao, Li-Ying; Kuo, Hsing-Tao; Kuo, Hsing-Tao; Chao, You-Chen; Tung, Shui-Yi; Tung, Shui-Yi; Yang, Sien-Sing; Kao, Jia-Horng; Kao, Jia-Horng; Su, Wei-Wen; Su, Wei-Wen; Lin, Chih-Lin; Lin, Chih-Lin; Yang, Hung-Chih; Yang, Hung-Chih; Chen, Pei-Jer; Chen, Pei-Jer; Chen, Ding-Shinn; Chen, Ding-Shinn; Liu, Chun-Jen; Liu, Chun-Jen; Yu, Ming-Lung;Lee, Chuan-Mo;Chen, Chi-Ling;Chuang, Wan-Long;Lu, Sheng-Nan;Liu, Chen-Hua;Wu, Shun-Sheng;Liao, Li-Ying;Kuo, Hsing-Tao;Chao, You-Chen;Tung, Shui-Yi;Yang, Sien-Sing;Kao, Jia-Horng;Su, Wei-Wen;Lin, Chih-Lin;Yang, Hung-Chih;Chen, Pei-Jer;Chen, Ding-Shinn;Liu, Chun-Jen |
| 臺大學術典藏 |
2018-09-10T09:39:55Z |
Serum hepatitis B surface antigen levels help predict disease progression in patients with low hepatitis B virus loads.
|
Tseng, Tai-Chung;Liu, Chun-Jen;Yang, Hung-Chih;Su, Tung-Hung;Wang, Chia-Chi;Chen, Chi-Ling;Hsu, Cheng-An;Kuo, Stephanie Fang-Tzu;Liu, Chen-Hua;Chen, Pei-Jer;Chen, Ding-Shinn;Kao, Jia-Horng; 陳定信 ;劉振驊 ;高嘉宏 ;楊宏志 ;蘇東弘 ;劉俊人 ;陳培哲 ;陳祈玲; CHUN-JEN LIU; Tseng, Tai-Chung; Tseng, Tai-Chung; Liu, Chun-Jen; PEI-JER CHEN; Yang, Hung-Chih; CHEN-HUA LIU; TUNG-HUNG SU; Su, Tung-Hung; DING-SHINN CHEN; Wang, Chia-Chi; Wang, Chia-Chi; Chen, Chi-Ling; Hsu, Cheng-An; Hsu, Cheng-An; Kuo, Stephanie Fang-Tzu; Kuo, Stephanie Fang-Tzu; Liu, Chen-Hua; Liu, Chen-Hua; Chen, Pei-Jer; Chen, Pei-Jer; Chen, Ding-Shinn; Chen, Ding-Shinn; Kao, Jia-Horng; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T09:39:54Z |
Pegylated interferon-α2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 1 receiving hemodialysis: a randomized trial.
|
Dai, Chia-Yen; Dai, Chia-Yen; Liang, Cheng-Chao; Huang, Jee-Fu; Hung, Peir-Haur; Hung, Peir-Haur; Tsai, Hung-Bin; Tsai, Hung-Bin; Tsai, Meng-Kun; Chen, Shih-I; Lin, Jou-Wei; Yang, Sheng-Shun; Su, Tung-Hung; Yang, Hung-Chih; Chen, Pei-Jer; Chen, Ding-Shinn; Chuang, Wan-Long; Yu, Ming-Lung; Kao, Jia-Horng; 陳定信; Liu, Chen-Hua;Huang, Chung-Feng;Liu, Chun-Jen;Dai, Chia-Yen;Liang, Cheng-Chao;Huang, Jee-Fu;Hung, Peir-Haur;Tsai, Hung-Bin;Tsai, Meng-Kun;Chen, Shih-I;Lin, Jou-Wei;Yang, Sheng-Shun;Su, Tung-Hung;Yang, Hung-Chih;Chen, Pei-Jer;Chen, Ding-Shinn;Chuang, Wan-Long;Yu, Ming-Lung;Kao, Jia-Horng; Liu, Chun-Jen; 陳定信;劉振驊;高嘉宏;楊宏志;蘇東弘;劉俊人;陳世宜;陳培哲;蔡孟昆;林昭維;蔡宏斌; Liu, Chen-Hua; Liu, Chen-Hua; CHEN-HUA LIU; Huang, Chung-Feng; Huang, Chung-Feng; Liu, Chun-Jen |
| 臺大學術典藏 |
2018-09-10T09:23:43Z |
Interleukin 28B genetic polymorphisms play a minor role in identifying optimal treatment duration in HCV genotype 1 slow responders to pegylated interferon plus ribavirin
|
Liu, Chen-Hua;Liang, Cheng-Chao;Liu, Chun-Jen;Tseng, Tai-Chung;Lin, Chih-Lin;Yang, Sheng-Shun;Su, Tung-Hung;Lin, Jou-Wei;Chen, Jun-Herng;Chen, Pei-Jer;Chen, Ding-Shinn;Kao, Jia-Horng; Liu, C.-H., Liang, C.-C., Liu, C.-J., Tseng, T.-C., Lin, C.-L., Yang, S.-S., Su, T.-H., Lin, J.-W., Chen, J.-H., Chen, P.-J., Chen, D.-S., Kao, J.-H.; 陳定信 ;劉振驊 ;高嘉宏 ;蘇東弘 ;劉俊人 ;陳培哲 ;陳俊恒 ;林昭維; 陳定信 ;劉振驊 ;高嘉宏 ;蘇東弘 ;劉俊人 ;陳培哲 ;陳俊恒 ;林昭維; Liu, Chen-Hua; Liu, Chen-Hua; CHUN-JEN LIU; Liang, Cheng-Chao; Liang, Cheng-Chao; PEI-JER CHEN; CHEN-HUA LIU; Liu, Chun-Jen; DING-SHINN CHEN; Tseng, Tai-Chung; TUNG-HUNG SU; Lin, Chih-Lin; Yang, Sheng-Shun; JIA-HORNG KAO; Su, Tung-Hung; Lin, Jou-Wei; Lin, Jou-Wei; Chen, Jun-Herng; Chen, Pei-Jer; Chen, Pei-Jer; Chen, Ding-Shinn; Kao, Jia-Horng; Kao, Jia-Horng |
| 臺大學術典藏 |
2018-09-10T09:23:42Z |
Interleukin 28B genetic polymorphisms and viral factors help identify HCV genotype-1 patients who benefit from 24-week pegylated interferon plus ribavirin therapy
|
Chen, Jun-Herng; Chen, Pei-Jer; Chen, Pei-Jer; Chen, Ding-Shinn; Kao, Jia-Horng; Chen, Jun-Herng; Lin, Jou-Wei; Lin, Jou-Wei; Hsu, Shih-Jer; Hsu, Shih-Jer; Su, Tung-Hung; Su, Tung-Hung; JIA-HORNG KAO; Lin, Chih-Lin; Yang, Sheng-Shun; Yang, Sheng-Shun; Liu, Chen-Hua;Liang, Cheng-Chao;Liu, Chun-Jen;Tseng, Tai-Chung;Lin, Chih-Lin;Yang, Sheng-Shun;Su, Tung-Hung;Hsu, Shih-Jer;Lin, Jou-Wei;Chen, Jun-Herng;Chen, Pei-Jer;Chen, Ding-Shinn;Kao, Jia-Horng; Liu, C.-H., Liang, C.-C., Liu, C.-J., Tseng, T.-C., Lin, C.-L., Yang, S.-S., Su, T.-H., Hsu, S.-J., Lin, J.-W., Chen, J.-H., Chen, P.-J., Chen, D.-S., Kao, J.-H.; 陳定信 ;劉振驊 ;高嘉宏 ;蘇東弘 ;徐士哲 ;劉俊人 ;陳培哲 ;陳俊恒 ;林昭維; 陳定信 ;劉振驊 ;高嘉宏 ;蘇東弘 ;徐士哲 ;劉俊人 ;陳培哲 ;陳俊恒 ;林昭維; Liu, Chen-Hua; CHUN-JEN LIU; Liu, Chen-Hua; Liang, Cheng-Chao; PEI-JER CHEN; Liang, Cheng-Chao; Liu, Chun-Jen; Liu, Chun-Jen; CHEN-HUA LIU; Tseng, Tai-Chung; DING-SHINN CHEN; Tseng, Tai-Chung; Lin, Chih-Lin; TUNG-HUNG SU |
| 臺大學術典藏 |
2018-09-10T09:14:10Z |
Young chronic hepatitis B patients with nucleos(t)ide analogue-induced hepatitis B e antigen seroconversion have a higher risk of HBV reactivation.
|
Tseng, Tai-Chung;Liu, Chun-Jen;Su, Tung-Hung;Yang, Hung-Chih;Wang, Chia-Chi;Chen, Chi-Ling;Kuo, Stephanie Fang-Tzu;Liu, Chen-Hua;Chen, Pei-Jer;Chen, Ding-Shinn;Kao, Jia-Horng; 陳定信 ;劉振驊 ;高嘉宏 ;楊宏志 ;劉俊人 ;陳培哲; CHUN-JEN LIU; Tseng, Tai-Chung; Liu, Chun-Jen; PEI-JER CHEN; Su, Tung-Hung; CHEN-HUA LIU; TUNG-HUNG SU; Yang, Hung-Chih; DING-SHINN CHEN; Wang, Chia-Chi; Chen, Chi-Ling; JIA-HORNG KAO; Kuo, Stephanie Fang-Tzu; Liu, Chen-Hua; Chen, Pei-Jer; Chen, Ding-Shinn; Kao, Jia-Horng |
顯示項目 31-40 / 153 (共16頁)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目
|
